ArticleExploration (Beijing, China)2026

A Nitric Oxide-Based STING Agonist Nanoadjuvant With ICD-Derived Membrane Antigens Unleashes Robust Antitumor Immunity.

Shuyu Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.